Correction: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
Gamez M, E Elhegni H, Fawaz S, Ho Ho K, W Campbell N, A Copland D, L Onions K, J Butler M, J Wasson E, Crompton M, D Ramnath R, Qiu Y, Yamaguchi Y, P Arkill K, O Bates D, E Turnbull J, V Zubkova O, I Welsh G, Atan D, C Satchell S, R Foster R.
Gamez M, et al. Among authors: yamaguchi y.
Cardiovasc Diabetol. 2024 Feb 20;23(1):74. doi: 10.1186/s12933-024-02170-w.
Cardiovasc Diabetol. 2024.
PMID: 38378538
Free PMC article.
No abstract available.